Epidermal growth breast cancers receptor erbb 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy14

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Cell Line Mammary Glands, Human Axilla Epithelial Cells Cells, Cultured Neoplastic Stem Cells Lymph Nodes Nipples Mammary Glands, Animal Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases39

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Invasiveness Neoplasm Metastasis Breast Neoplasms, Male Lung Neoplasms Carcinoma, Lobular Carcinoma Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Genetic Predisposition to Disease Ovarian Neoplasms Neoplasms, Hormone-Dependent Lymphatic Metastasis Neoplasm Recurrence, Local Neoplasms Disease Progression Prostatic Neoplasms Cell Transformation, Neoplastic Fibrocystic Breast Disease Adenocarcinoma Colonic Neoplasms Carcinoma, Squamous Cell Bone Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Ductal Stomach Neoplasms Carcinoma in Situ Pancreatic Neoplasms Inflammatory Breast Neoplasms Triple Negative Breast Neoplasms Neoplasms, Second Primary Neovascularization, Pathologic Colorectal Neoplasms Uterine Cervical Neoplasms Neoplastic Cells, Circulating Neoplasms, Basal Cell Fibroadenoma

Chemicals and Drugs72

Neuregulin-1 Neuregulins Receptor, Epidermal Growth Factor Receptor, erbB-3 Epidermal Growth Factor Receptor, erbB-2 Receptors, Estrogen Receptors, Progesterone Tamoxifen Antineoplastic Agents Tumor Markers, Biological Quinazolines Antineoplastic Agents, Hormonal Neoplasm Proteins RNA, Messenger Antibodies, Monoclonal, Humanized Estrogen Receptor alpha Estrogens Transforming Growth Factor alpha Antibodies, Monoclonal RNA, Small Interfering BRCA2 Protein Estrogen Antagonists BRCA1 Protein Aromatase Inhibitors DNA, Neoplasm Protein Kinase Inhibitors Oncogene Proteins v-erbB Nitriles Estradiol Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins Fluorouracil Intercellular Signaling Peptides and Proteins Estrogen Receptor Modulators Tyrphostins Tumor Suppressor Protein p53 Cyclophosphamide Phosphatidylinositol 3-Kinases Epirubicin Ki-67 Antigen Tumor Suppressor Proteins Paclitaxel Enzyme Inhibitors Protein-Tyrosine Kinases RNA, Neoplasm Selective Estrogen Receptor Modulators Transcription Factors Antigens, Neoplasm DNA-Binding Proteins Protein-Serine-Threonine Kinases Cancer Vaccines Anticarcinogenic Agents Growth Substances Ligands Mitogen-Activated Protein Kinases Mucin-1 Triazoles DNA Primers Extracellular Signal-Regulated MAP Kinases Antigens, CD24 Antibiotics, Antineoplastic Cyclin D1 Adaptor Proteins, Signal Transducing Membrane Proteins Tyrosine Receptors, Cell Surface MicroRNAs Anthracyclines Transforming Growth Factors ras Proteins Recombinant Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Mammography Prognosis Neoplasm Staging Immunohistochemistry Mastectomy Early Detection of Cancer Chemotherapy, Adjuvant Risk Factors Antineoplastic Combined Chemotherapy Protocols Mammary Neoplasms, Experimental Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Disease-Free Survival Gene Expression Profiling Case-Control Studies Survival Rate Breast Self-Examination Follow-Up Studies Xenograft Model Antitumor Assays Risk Transfection Treatment Outcome Prospective Studies Retrospective Studies Risk Assessment Neoplasm Transplantation Transplantation, Heterologous Mastectomy, Segmental Odds Ratio Incidence Tissue Array Analysis Cohort Studies Multivariate Analysis Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Kaplan-Meier Estimate Registries Tumor Burden Immunoenzyme Techniques Predictive Value of Tests Polymerase Chain Reaction Ultrasonography, Mammary In Situ Hybridization, Fluorescence Combined Modality Therapy Models, Biological Molecular Targeted Therapy Logistic Models SEER Program Reproducibility of Results Questionnaires Breast Implants Clinical Trials as Topic Neoadjuvant Therapy Drug Screening Assays, Antitumor Neoplasm Grading DNA Mutational Analysis Radiotherapy, Adjuvant Gene Knockdown Techniques Mass Screening Confidence Intervals Mammaplasty Drug Administration Schedule Proportional Hazards Models Immunoblotting Genetic Testing Biopsy Radiotherapy Biopsy, Needle Sentinel Lymph Node Biopsy Flow Cytometry

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes52

Genes, erbB Gene Expression Regulation, Neoplastic Signal Transduction Cell Proliferation Drug Resistance, Neoplasm Phosphorylation Genes, erbB-2 Genes, BRCA1 Postmenopause Cell Division Mutation Genetic Predisposition to Disease Premenopause Breast Feeding Apoptosis Risk Cell Movement Menopause Transfection Time Factors Down-Regulation Genes, BRCA2 Gene Amplification Odds Ratio Dose-Response Relationship, Drug Enzyme Activation Sensitivity and Specificity Base Sequence Cell Growth Processes Up-Regulation Promoter Regions, Genetic RNA Interference Cell Survival Gene Expression Cell Cycle Genotype Protein Binding Germ-Line Mutation Polymorphism, Genetic Drug Synergism Amino Acid Sequence Phenotype DNA Methylation Gene Silencing Transcription, Genetic MAP Kinase Signaling System Genes, erbB-1 Parity Epithelial-Mesenchymal Transition Genes, Tumor Suppressor Genes, Neoplasm Genes, p53

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Molecular Sequence Data Incidence Base Sequence Registries SEER Program Questionnaires Amino Acid Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care30

Risk Factors Survival Analysis Disease-Free Survival Case-Control Studies Survival Rate Follow-Up Studies Risk Treatment Outcome Prospective Studies Retrospective Studies Risk Assessment Age Factors Odds Ratio Incidence Cohort Studies Multivariate Analysis Sensitivity and Specificity Kaplan-Meier Estimate Registries Predictive Value of Tests Logistic Models SEER Program Reproducibility of Results Questionnaires Clinical Trials as Topic Mass Screening Confidence Intervals Proportional Hazards Models Genetic Testing Parity

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Neuregulin-1 Neuregulins Receptor, Epidermal Growth Factor Receptor, erbB-3 Epidermal Growth Factor Receptor, erbB-2 Breast Breast Neoplasms Carcinoma, Ductal, Breast Cell Line, Tumor Receptors, Estrogen Genes, erbB Gene Expression Regulation, Neoplastic Receptors, Progesterone Breast Diseases Tamoxifen Neoplasm Invasiveness Neoplasm Metastasis Antineoplastic Agents Mammography Prognosis Tumor Markers, Biological Signal Transduction Quinazolines Tumor Cells, Cultured Mice, Nude Antineoplastic Agents, Hormonal Neoplasm Staging Breast Neoplasms, Male Neoplasm Proteins Cell Proliferation Immunohistochemistry Drug Resistance, Neoplasm Phosphorylation Genes, erbB-2 Mastectomy Early Detection of Cancer Lung Neoplasms Chemotherapy, Adjuvant RNA, Messenger Risk Factors Genes, BRCA1 Carcinoma, Lobular Postmenopause Antineoplastic Combined Chemotherapy Protocols Carcinoma Cell Division MCF-7 Cells Antibodies, Monoclonal, Humanized Carcinoma, Intraductal, Noninfiltrating Mammary Neoplasms, Experimental Mutation Survival Analysis Reverse Transcriptase Polymerase Chain Reaction Estrogen Receptor alpha Blotting, Western Disease-Free Survival Genetic Predisposition to Disease Gene Expression Profiling Estrogens Ovarian Neoplasms Transforming Growth Factor alpha Case-Control Studies Premenopause Breast Feeding Neoplasms, Hormone-Dependent Lymphatic Metastasis Antibodies, Monoclonal Neoplasm Recurrence, Local Survival Rate Neoplasms Breast Self-Examination Follow-Up Studies Apoptosis Xenograft Model Antitumor Assays Risk Cell Movement Disease Progression RNA, Small Interfering Menopause Transfection Cell Line Time Factors Mammary Glands, Human Down-Regulation BRCA2 Protein Treatment Outcome Estrogen Antagonists Prospective Studies BRCA1 Protein Retrospective Studies Prostatic Neoplasms Cell Transformation, Neoplastic Fibrocystic Breast Disease Genes, BRCA2 Aromatase Inhibitors DNA, Neoplasm Risk Assessment Gene Amplification Age Factors

No FAQ available that match "epidermal growth breast cancers receptor erbb 2"